Flooded by the torrent: the COVID-19 drug pipeline
The coronavirus disease 2019 (COVID-19) drug pipeline is not growing at quite the same speed as the pandemic. But its rate of expansion is nevertheless cause for pause. In the months since COVID-19 has spread, researchers have launched more than 180 clinical trials of everything from repurposed antivirals and immuno modulators to unproven cell therapies and vitamin C. A further 150 trials are preparing to recruit patients.
